Thanks @Kryptonite
Good to see Acadia progress ROW opportunities ... aiming for Canada by end 2024
I think this slide is also important:
Note NNZ-2591 is back in their slide pack as ACP-2591 for Rett Syndrome and Fragile X .... pink bar above
Footnote: "3 The safety and efficacy of these investigational agents have not been established. There is no guarantee these investigational agents will be filed with or approved by any regulatory agency.
Acadia, page-76
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$21.09 |
Change
-0.710(3.26%) |
Mkt cap ! $2.693B | |||
| Open | High | Low | Value | Volume |
| $21.74 | $21.78 | $21.03 | $7.303M | 342.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 377 | $21.08 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $21.10 | 257 | 1 |
View Market Depth
| Last trade - 16.10pm 17/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$21.16 |
Change
-0.710 ( 3.28 %) |
||||
| Open | High | Low | Volume | ||
| $21.72 | $21.72 | $21.03 | 92331 | ||
| Last updated 15.59pm 17/05/2024 ? | |||||
| NEU (ASX) Chart |